Results from 22 years of Followup in the Göteborg Randomized Population-Based Prostate Cancer Screening Trial-Reference-Cited by-同舟云学术

Results from 22 years of Followup in the Göteborg Randomized Population-Based Prostate Cancer Screening Trial

Published:2022-08 Issue:2 Volume:208 Page:292-300
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Frånlund Maria¹^ORCID,Månsson Marianne¹,Godtman Rebecka Arnsrud¹,Aus Gunnar²,Holmberg Erik³,Kollberg Karin Stinesen¹,Lodding Pär¹,Pihl Carl-Gustaf⁴,Stranne Johan¹,Lilja Hans⁵⁶⁷⁸⁹,Hugosson Jonas¹

Affiliation:

1. Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden

2. Department of Urology, Carlanderska Hospital, Gothenburg, Sweden

3. Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden

4. Department of Pathology, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden

5. Department of Surgery (Urology Service), Memorial Sloan Kettering Cancer Center, New York, New York

6. Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York

7. Department of Medicine (Genitourinary Oncology Service), Memorial Sloan Kettering Cancer Center, New York, New York

8. Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom

9. Department of Translational Medicine, Lund University, Malmö, Sweden

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Link

http://www.auajournals.org/doi/pdf/10.1097/JU.0000000000002696

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment?;European Urology;2024-09

2. Erectile Dysfunction and Penile Bulb Dose Following Definitive Prostate Radiation Therapy;International Journal of Cancer Management;2024-08-24

3. Targeted Prostate Health Checks, a novel system to identify men with prostate cancer—A pilot study;BJUI Compass;2024-08-15

4. How a population-based cohort of men estimate lifetime risk of prostate cancer in a survey before entering a prostate cancer screening trial in Sweden?;BMJ Open;2024-08

5. Prostate Cancers in the Prostate-specific Antigen Interval of 1.8–3 ng/ml: Results from the Göteborg-2 Prostate Cancer Screening Trial;European Urology;2024-08